Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of AT1001 in Patients With Fabry Disease

This study has been completed.
Information provided by (Responsible Party):
Amicus Therapeutics Identifier:
First received: September 13, 2005
Last updated: May 5, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 17, 2010